Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease

Apolipoprotein E ɛ4 allele is a common susceptibility gene for late-onset Alzheimer's disease. Brain vascular and metabolic deficits can occur in cognitively normal apolipoprotein E ɛ4 carriers decades before the onset of Alzheimer's disease. The goal of this study was to determine whether...

Full description

Saved in:
Bibliographic Details
Published inJournal of cerebral blood flow and metabolism Vol. 37; no. 1; pp. 217 - 226
Main Authors Lin, Ai-Ling, Jahrling, Jordan B, Zhang, Wei, DeRosa, Nicholas, Bakshi, Vikas, Romero, Peter, Galvan, Veronica, Richardson, Arlan
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.01.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Apolipoprotein E ɛ4 allele is a common susceptibility gene for late-onset Alzheimer's disease. Brain vascular and metabolic deficits can occur in cognitively normal apolipoprotein E ɛ4 carriers decades before the onset of Alzheimer's disease. The goal of this study was to determine whether early intervention using rapamycin could restore neurovascular and neurometabolic functions, and thus impede pathological progression of Alzheimer's disease-like symptoms in pre-symptomatic Apolipoprotein E ɛ4 transgenic mice. Using in vivo, multimodal neuroimaging, we found that apolipoprotein E ɛ4 mice treated with rapamycin had restored cerebral blood flow, blood–brain barrier integrity and glucose metabolism, compared to age- and gender-matched wild-type controls. The preserved vasculature and metabolism were associated with amelioration of incipient learning deficits. We also found that rapamycin restored the levels of the proinflammatory cyclophilin A in vasculature, which may contribute to the preservation of cerebrovascular function in the apolipoprotein E ɛ4 transgenics. Our results show that rapamycin improves functional outcomes in this mouse model and may have potential as an effective intervention to block progression of vascular, metabolic and early cognitive deficits in human Apolipoprotein E ɛ4 carriers. As rapamycin is FDA-approved and neuroimaging is readily used in humans, the results of the present study may provide the basis for future Alzheimer's disease intervention studies in human subjects.
AbstractList Apolipoprotein E ɛ4 allele is a common susceptibility gene for late-onset Alzheimer's disease. Brain vascular and metabolic deficits can occur in cognitively normal apolipoprotein E ɛ4 carriers decades before the onset of Alzheimer's disease. The goal of this study was to determine whether early intervention using rapamycin could restore neurovascular and neurometabolic functions, and thus impede pathological progression of Alzheimer's disease-like symptoms in pre-symptomatic Apolipoprotein E ɛ4 transgenic mice. Using in vivo, multimodal neuroimaging, we found that apolipoprotein E ɛ4 mice treated with rapamycin had restored cerebral blood flow, blood–brain barrier integrity and glucose metabolism, compared to age- and gender-matched wild-type controls. The preserved vasculature and metabolism were associated with amelioration of incipient learning deficits. We also found that rapamycin restored the levels of the proinflammatory cyclophilin A in vasculature, which may contribute to the preservation of cerebrovascular function in the apolipoprotein E ɛ4 transgenics. Our results show that rapamycin improves functional outcomes in this mouse model and may have potential as an effective intervention to block progression of vascular, metabolic and early cognitive deficits in human Apolipoprotein E ɛ4 carriers. As rapamycin is FDA-approved and neuroimaging is readily used in humans, the results of the present study may provide the basis for future Alzheimer's disease intervention studies in human subjects.
Apolipoprotein E 4 allele is a common susceptibility gene for late-onset Alzheimer's disease. Brain vascular and metabolic deficits can occur in cognitively normal apolipoprotein E 4 carriers decades before the onset of Alzheimer's disease. The goal of this study was to determine whether early intervention using rapamycin could restore neurovascular and neurometabolic functions, and thus impede pathological progression of Alzheimer's disease-like symptoms in pre-symptomatic Apolipoprotein E 4 transgenic mice. Using in vivo, multimodal neuroimaging, we found that apolipoprotein E 4 mice treated with rapamycin had restored cerebral blood flow, blood-brain barrier integrity and glucose metabolism, compared to age- and gender-matched wild-type controls. The preserved vasculature and metabolism were associated with amelioration of incipient learning deficits. We also found that rapamycin restored the levels of the proinflammatory cyclophilin A in vasculature, which may contribute to the preservation of cerebrovascular function in the apolipoprotein E 4 transgenics. Our results show that rapamycin improves functional outcomes in this mouse model and may have potential as an effective intervention to block progression of vascular, metabolic and early cognitive deficits in human Apolipoprotein E 4 carriers. As rapamycin is FDA-approved and neuroimaging is readily used in humans, the results of the present study may provide the basis for future Alzheimer's disease intervention studies in human subjects.
Author Bakshi, Vikas
Richardson, Arlan
Zhang, Wei
Lin, Ai-Ling
Jahrling, Jordan B
Galvan, Veronica
DeRosa, Nicholas
Romero, Peter
AuthorAffiliation 7 Geriatric Medicine, University of Oklahoma Health Science Center and Oklahoma City VA Medical Center, Oklahoma City, OK, USA
2 Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA
3 Department of Biomedical Engineering, University of Kentucky, Lexington, KY, USA
6 Department of Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
1 Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA
5 Research Imaging Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
4 Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
AuthorAffiliation_xml – name: 2 Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA
– name: 1 Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA
– name: 5 Research Imaging Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
– name: 6 Department of Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
– name: 4 Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
– name: 3 Department of Biomedical Engineering, University of Kentucky, Lexington, KY, USA
– name: 7 Geriatric Medicine, University of Oklahoma Health Science Center and Oklahoma City VA Medical Center, Oklahoma City, OK, USA
Author_xml – sequence: 1
  givenname: Ai-Ling
  surname: Lin
  fullname: Lin, Ai-Ling
  email: ailing.lin@uky.edu
– sequence: 2
  givenname: Jordan B
  surname: Jahrling
  fullname: Jahrling, Jordan B
– sequence: 3
  givenname: Wei
  surname: Zhang
  fullname: Zhang, Wei
– sequence: 4
  givenname: Nicholas
  surname: DeRosa
  fullname: DeRosa, Nicholas
– sequence: 5
  givenname: Vikas
  surname: Bakshi
  fullname: Bakshi, Vikas
– sequence: 6
  givenname: Peter
  surname: Romero
  fullname: Romero, Peter
– sequence: 7
  givenname: Veronica
  surname: Galvan
  fullname: Galvan, Veronica
– sequence: 8
  givenname: Arlan
  surname: Richardson
  fullname: Richardson, Arlan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26721390$$D View this record in MEDLINE/PubMed
BookMark eNqNUU2LFDEQDbLizq7ePUmOHmxNJZ1O90VYlvUDFgRR8NZUp6tnsnQnbdKzy3jy7i_w7_lLzDDrooLgqUjeB1XvnbAjHzwx9hjEcwBjXghpoDL1J9CVBG30PbYCrZvCCKiO2GoPF3v8mJ2kdCWEqJXWD9ixrIwE1YgV-_YeZ5x21nkeKdktJX6NeY4Yn_GJFuzC6CxH3_ORMHrn17ynwVm3JJ5FOGd8DnMMC-XnRcmXiD6tyWfV5CzxG7ds-BypSLtpXsKES0bOxi8bchPFH1-_J967RJjoIbs_4Jjo0e08ZR9fXXw4f1Ncvnv99vzssrAayqXopB1U3ZRlqUytqRsUDkYKUVrshZCqQjAWBUBjlUbo67LrFYFUHeRPq9Qpe3nwnbfdRL0ln3ce2zm6CeOuDejaPxHvNu06XLc6hw0gssHTW4MYPufIlnZyydI4oqewTS3UuikbJRv5H1RZVVrUsslUcaDaGFKKNNxtBKLd193-XXeWPPn9kjvBr34zoTgQEq6pvQrb6HOy_zb8CTy1uH0
CitedBy_id crossref_primary_10_3390_cells10030694
crossref_primary_10_1016_j_envres_2019_108537
crossref_primary_10_3389_fcell_2021_633331
crossref_primary_10_1016_j_conb_2022_102594
crossref_primary_10_3389_fnagi_2017_00298
crossref_primary_10_1113_EP087207
crossref_primary_10_3390_ijms21134621
crossref_primary_10_1016_j_bcp_2023_115576
crossref_primary_10_3389_fpsyt_2020_586083
crossref_primary_10_1093_brain_awab268
crossref_primary_10_3389_fnagi_2018_00263
crossref_primary_10_1007_s11357_024_01198_w
crossref_primary_10_1016_j_apsb_2022_01_008
crossref_primary_10_1016_j_jmb_2020_01_024
crossref_primary_10_1016_j_nbd_2020_104834
crossref_primary_10_1038_s41467_023_37840_y
crossref_primary_10_1093_gerona_glw090
crossref_primary_10_1523_JNEUROSCI_2144_20_2021
crossref_primary_10_3389_fnins_2019_00308
crossref_primary_10_1002_bies_201700062
crossref_primary_10_31491_APT_2019_12_002
crossref_primary_10_1007_s11357_023_00786_6
crossref_primary_10_18632_oncotarget_27926
crossref_primary_10_3390_cells8020182
crossref_primary_10_1097_MOL_0000000000000566
crossref_primary_10_3390_pharmaceutics15041086
crossref_primary_10_1007_s13311_019_00742_3
crossref_primary_10_1111_bph_16263
crossref_primary_10_1016_j_regg_2017_02_007
crossref_primary_10_3389_fnmol_2022_1019343
crossref_primary_10_1152_ajpheart_00570_2017
crossref_primary_10_3389_fphar_2024_1366061
crossref_primary_10_1177_0271678X17746186
crossref_primary_10_3389_fnagi_2021_749026
crossref_primary_10_1159_000485381
crossref_primary_10_3389_fcell_2022_837337
crossref_primary_10_1016_j_mad_2020_111391
crossref_primary_10_1093_brain_awac174
crossref_primary_10_1002_iub_2324
crossref_primary_10_3233_JAD_231249
crossref_primary_10_3233_JAD_210602
crossref_primary_10_1186_s12883_024_03596_1
crossref_primary_10_1038_s41467_020_16984_1
crossref_primary_10_3233_JAD_221064
crossref_primary_10_1038_s41569_018_0030_z
crossref_primary_10_1177_0271678X18807309
crossref_primary_10_1042_NS20180203
crossref_primary_10_1016_j_phymed_2023_154916
crossref_primary_10_3390_ijms23073785
crossref_primary_10_1093_gerona_glz135
crossref_primary_10_3390_ijms21238948
crossref_primary_10_1093_gerona_glz056
crossref_primary_10_4103_1673_5374_322452
crossref_primary_10_1093_gerona_glw064
crossref_primary_10_1007_s11357_017_9991_9
crossref_primary_10_1007_s12031_019_01397_7
crossref_primary_10_1007_s11064_022_03628_7
crossref_primary_10_1016_j_nbd_2020_104742
crossref_primary_10_14336_AD_2023_0621
crossref_primary_10_3390_ijms242417478
crossref_primary_10_1038_s41467_018_06301_2
crossref_primary_10_1097_FJC_0000000000001208
crossref_primary_10_2174_1567205016666190301111120
crossref_primary_10_3389_fnagi_2022_928925
crossref_primary_10_1038_s41573_020_0067_7
crossref_primary_10_1186_s13024_022_00566_4
crossref_primary_10_3389_fnins_2018_00372
crossref_primary_10_1016_j_jns_2019_02_022
crossref_primary_10_3389_fnagi_2018_00225
crossref_primary_10_3389_fphys_2021_825816
crossref_primary_10_1038_s41598_018_25190_5
crossref_primary_10_3389_fnagi_2018_00180
crossref_primary_10_3233_JAD_230658
crossref_primary_10_1016_j_nbd_2020_104755
crossref_primary_10_1556_2060_105_2018_4_32
crossref_primary_10_3390_nu13124317
crossref_primary_10_1111_ejn_15685
crossref_primary_10_1007_s11357_020_00274_1
crossref_primary_10_3390_biom12050694
crossref_primary_10_3892_ijmm_2019_4198
crossref_primary_10_1016_j_biopsych_2019_05_008
crossref_primary_10_1016_j_exger_2023_112248
crossref_primary_10_1016_j_neuint_2022_105311
crossref_primary_10_3389_fphys_2018_01520
crossref_primary_10_1016_j_expneurol_2018_09_009
crossref_primary_10_1161_CIRCRESAHA_118_311378
crossref_primary_10_1007_s11357_021_00363_9
crossref_primary_10_1152_ajpheart_00514_2017
crossref_primary_10_1126_scitranslmed_aar4289
crossref_primary_10_3389_fnmol_2018_00297
crossref_primary_10_1177_0271678X241261942
crossref_primary_10_1016_j_bbr_2024_114889
crossref_primary_10_3389_fcell_2019_00179
crossref_primary_10_3389_fgene_2017_00113
crossref_primary_10_1111_cns_14463
crossref_primary_10_1007_s11357_019_00071_5
crossref_primary_10_1111_acel_13057
crossref_primary_10_1152_ajpheart_00776_2018
crossref_primary_10_1007_s12035_018_0892_4
crossref_primary_10_3390_ijms21228559
crossref_primary_10_1080_00207454_2023_2210409
crossref_primary_10_3233_JAD_210492
crossref_primary_10_3390_biomedicines9111625
crossref_primary_10_3389_fnmol_2022_944883
crossref_primary_10_1016_j_expneurol_2018_09_011
crossref_primary_10_1007_s11357_020_00252_7
crossref_primary_10_2147_CIA_S429440
Cites_doi 10.2147/CLEP.S37929
10.1016/j.neuron.2004.08.028
10.1001/archneurol.2009.913
10.1016/j.nut.2010.07.021
10.18632/aging.100688
10.1016/j.neurobiolaging.2015.03.012
10.1007/s11523-011-0174-9
10.1073/pnas.2635903100
10.1016/S0197-4580(00)00130-5
10.1073/pnas.0500579102
10.1016/j.exger.2014.12.002
10.1038/jcbfm.2010.220
10.1073/pnas.061509598
10.1038/jcbfm.2013.82
10.1038/jcbfm.2008.62
10.1074/jbc.M112.407957
10.1002/mrm.22667
10.1126/scitranslmed.3009892
10.1038/jcbfm.2013.116
10.1155/2012/907409
10.1159/000354777
10.1016/j.neurobiolaging.2012.04.017
10.1038/jcbfm.2014.172
10.3233/JAD-2011-110899
10.1007/s11523-011-0178-5
10.1073/pnas.0909711107
10.1038/jcbfm.2014.114
10.1038/nature11087
10.2217/bmm.14.42
10.1042/BJ20140291
10.3233/JAD-2011-0010
10.1523/JNEUROSCI.0671-06.2006
10.1371/journal.pone.0009979
10.1038/nm0497-421
10.1073/pnas.0509695103
10.3233/JAD-2011-110479
10.1111/j.1749-6632.1997.tb48479.x
10.1126/science.3260686
10.1038/nrn3114
10.1126/science.8346443
10.3233/JAD-148007
10.1038/nrneurol.2012.263
10.1001/jamaneurol.2013.2152
10.2217/fnl.14.13
ContentType Journal Article
Copyright The Author(s) 2015
The Author(s) 2015.
The Author(s) 2015 2015 International Society for Cerebral Blood Flow and Metabolism
Copyright_xml – notice: The Author(s) 2015
– notice: The Author(s) 2015.
– notice: The Author(s) 2015 2015 International Society for Cerebral Blood Flow and Metabolism
DBID AFRWT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7TK
5PM
DOI 10.1177/0271678X15621575
DatabaseName Sage Journals GOLD Open Access 2024
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
Neurosciences Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitleList CrossRef
MEDLINE


Neurosciences Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: AFRWT
  name: SAGE Open Access
  url: http://journals.sagepub.com/
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1559-7016
EndPage 226
ExternalDocumentID 10_1177_0271678X15621575
26721390
10.1177_0271678X15621575
Genre Journal Article
GrantInformation_xml – fundername: NIA NIH HHS
  grantid: P30 AG013319
– fundername: NCATS NIH HHS
  grantid: UL1 TR001120
– fundername: NIA NIH HHS
  grantid: R01 AG054459
– fundername: NCATS NIH HHS
  grantid: KL2 TR001118
– fundername: BLRD VA
  grantid: I01 BX002211
– fundername: NIA NIH HHS
  grantid: T32 AG021890
– fundername: NIA NIH HHS
  grantid: K01 AG040164
GroupedDBID ---
-Q-
-TM
.55
.GJ
0R~
29K
2WC
36B
39C
3O-
3V.
4.4
53G
54M
5GY
5RE
5VS
70F
7X7
88A
88E
8AO
8FE
8FH
8FI
8FJ
8R4
8R5
AABMB
AACKU
AACMV
AADUE
AAEWN
AAGGD
AAGMC
AAJIQ
AAJPV
AAKGS
AAMGE
AANSI
AAPEO
AAQGT
AAQXH
AARDL
AARIX
AATAA
AATBZ
AAUAS
AAVDI
AAXOT
AAYTG
AAZBJ
ABAWP
ABAWZ
ABCCA
ABDWY
ABEIX
ABFWQ
ABHKI
ABJNI
ABKRH
ABLUO
ABNCE
ABPGX
ABPNF
ABQKF
ABQNX
ABQXT
ABRHV
ABUWG
ABVFX
ABXGC
ABYTW
ACARO
ACDSZ
ACDXX
ACFEJ
ACFMA
ACGBL
ACGFO
ACGFS
ACGZU
ACJTF
ACLFY
ACLHI
ACNXM
ACOFE
ACOXC
ACPRK
ACROE
ACSIQ
ACTQU
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADEIA
ADMPF
ADRRZ
ADTBJ
ADUKL
ADZZY
AECGH
AENEX
AEPTA
AEQLS
AESZF
AEUHG
AEUIJ
AEWDL
AEWHI
AEXFG
AEXNY
AFEET
AFFNX
AFFZS
AFKRA
AFKRG
AFMOU
AFOSN
AFQAA
AFRWT
AFUIA
AGKLV
AGNHF
AGWFA
AHMBA
AIGRN
AIOMO
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
AJXAJ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALTZF
AMCVQ
ANDLU
AOIJS
ARTOV
AUTPY
AYAKG
B8M
BAWUL
BBNVY
BBRGL
BDDNI
BENPR
BHPHI
BKIIM
BKSCU
BPACV
BPHCQ
BSEHC
BVXVI
BWJAD
C45
CAG
CBRKF
CCPQU
CDWPY
CFDXU
COF
CORYS
CQQTX
CS3
CUTAK
D-I
DC-
DC.
DIK
DOPDO
DV7
E3Z
EBS
EE.
EJD
EMOBN
F5P
FHBDP
FYUFA
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
GX1
HCIFZ
HMCUK
HYE
HZ~
J8X
JCYGO
JSO
K.F
KQ8
LK8
M0L
M1P
M4V
M7P
O9-
OK1
OVD
P2P
P6G
PQQKQ
PROAC
PSQYO
Q1R
Q2X
RNS
RNTTT
ROL
RPM
SCNPE
SFC
SHG
SPQ
SPV
TEORI
TR2
UKHRP
W2D
X7M
YFH
YOC
ZGI
ZONMY
ZPPRI
ZRKOI
ZSSAH
ZXP
ACJER
AFVCE
AJXGE
ALKWR
CGR
CUY
CVF
ECM
EIF
H13
NPM
AAYXX
ADVBO
CITATION
7X8
7TK
5PM
ID FETCH-LOGICAL-c514t-b2cf3894443785ebf3af72004cad00236a17ca0119c35a1d84bd3e123b1011c33
IEDL.DBID RPM
ISSN 0271-678X
IngestDate Tue Sep 17 21:18:05 EDT 2024
Fri Oct 25 21:11:04 EDT 2024
Fri Oct 25 08:11:11 EDT 2024
Fri Dec 06 07:52:12 EST 2024
Wed Oct 16 00:46:43 EDT 2024
Tue Jul 16 20:50:18 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Brain imaging
blood–brain barrier
cognition
Alzheimer’s disease
cerebral glucose metabolism
inflammation
APOE4
cerebral blood flow
rapamycin
Language English
License This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
The Author(s) 2015.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c514t-b2cf3894443785ebf3af72004cad00236a17ca0119c35a1d84bd3e123b1011c33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167110/
PMID 26721390
PQID 1826650829
PQPubID 23479
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5167110
proquest_miscellaneous_1859493292
proquest_miscellaneous_1826650829
crossref_primary_10_1177_0271678X15621575
pubmed_primary_26721390
sage_journals_10_1177_0271678X15621575
PublicationCentury 2000
PublicationDate 2017-01-01
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – month: 01
  year: 2017
  text: 2017-01-01
  day: 01
PublicationDecade 2010
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: United States
– name: Sage UK: London, England
PublicationTitle Journal of cerebral blood flow and metabolism
PublicationTitleAlternate J Cereb Blood Flow Metab
PublicationYear 2017
Publisher SAGE Publications
Publisher_xml – name: SAGE Publications
References Fox, Raichle, Mintun 1988; 241
Poels, Ikram, Vernooij 2008; 28
Reiman, Chen, Alexander 2005; 102
Zlokovic 2011; 12
Fleisher, Chen, Liu 2013; 34
Lin, Pulliam, Deepa 2013; 33
Liu, Kanekiyo, Xu 2013; 9
Pulliam, Deepa, Liu 2014; 462
Dash, Orsi, Moore 2006; 26
Alata, Ye, St-Amour 2015; 35
Nagata, Kondoh, Atchison 2000; 21
Uh, Lin, Lee 2011; 65
Corder, Saunders, Strittmatter 1993; 261
Salomon-Zimri, Boehm-Cagan, Liraz 2014; 13
Spilman, Podlutskaya, Hart 2010; 5
Yin, Turner, Lin 2011; 27
Kehoe, McNulty, Mullins 2014; 8
Lin, Gao, Duong 2010; 2
Galvan, Gorostiza, Banwait 2006; 103
Steiner, Connolly, Valentine 1997; 3
Nagata, Buchan, Yokoyama 1997; 826
Thambisetty, Beason-Held, An 2010; 67
Lin, Rothman 2014; 9
Bell, Winkler, Singh 2012; 485
Reiman, Caselli, Chen 2001; 98
Reiman, Chen, Alexander 2004; 101
Mielke, Vemuri, Rocca 2014; 6
Soefje, Karnad, Brenner 2011; 6
Lin, Laird, Fox 2012; 2012
Stranahan, Mattson 2012; 30
Lin, Coman, Jiang 2014; 34
Halliday, Rege, Ma
Brommelhoff, Sultzer 2015; 45
Lin, Zhang, Gao 2015; 36
Eichenbaum 2004; 44
Lin, Zheng, Halloran 2013; 33
Cunnane, Nugent, Roy 2011; 27
Zlokovic 2013; 70
Lin, Fox, Hardies 2010; 107
Richardson, Galvan, Lin 2014; 68
Kilkenny, Browne, Cuthill 2011; 31
Mannick, Del Giudice, Lattanzi, Valiante, Praestgaard, Huang 2014; 6
Youmans, Tai, Nwabuisi-Heath 2012; 287
Liu, Diaz, Fernandez 2014; 6
Austin, Nair, Meier 2011; 26
Hurez, Dao, Liu
Alvarado, Mita, Vemulapalli 2011; 6
Mita, Mita, Rowinsky 2003; 2
27385004 - Oncotarget. 2016 Jul 19;7(29):44873-44874
bibr3-0271678X15621575
bibr33-0271678X15621575
bibr8-0271678X15621575
bibr20-0271678X15621575
bibr41-0271678X15621575
bibr16-0271678X15621575
bibr46-0271678X15621575
bibr17-0271678X15621575
bibr11-0271678X15621575
bibr37-0271678X15621575
bibr4-0271678X15621575
Mita MM (bibr47-0271678X15621575) 2003; 2
bibr24-0271678X15621575
bibr2-0271678X15621575
Lin AL (bibr29-0271678X15621575) 2010; 2
bibr39-0271678X15621575
bibr21-0271678X15621575
bibr13-0271678X15621575
bibr34-0271678X15621575
bibr42-0271678X15621575
bibr12-0271678X15621575
bibr7-0271678X15621575
bibr25-0271678X15621575
Halliday MR (bibr26-0271678X15621575)
bibr38-0271678X15621575
bibr14-0271678X15621575
bibr19-0271678X15621575
bibr27-0271678X15621575
bibr31-0271678X15621575
bibr30-0271678X15621575
bibr6-0271678X15621575
bibr48-0271678X15621575
bibr43-0271678X15621575
bibr35-0271678X15621575
bibr28-0271678X15621575
bibr22-0271678X15621575
bibr9-0271678X15621575
bibr40-0271678X15621575
bibr18-0271678X15621575
bibr15-0271678X15621575
bibr32-0271678X15621575
bibr45-0271678X15621575
bibr36-0271678X15621575
Hurez V (bibr44-0271678X15621575)
bibr5-0271678X15621575
bibr10-0271678X15621575
bibr1-0271678X15621575
bibr23-0271678X15621575
References_xml – volume: 21
  start-page: 301
  year: 2000
  end-page: 307
  article-title: Vascular and metabolic reserve in Alzheimer's disease
  publication-title: Neurobiol Aging
  contributor:
    fullname: Atchison
– volume: 826
  start-page: 272
  year: 1997
  end-page: 281
  article-title: Misery perfusion with preserved vascular reactivity in Alzheimer's disease
  publication-title: Ann N Y Acad Sci
  contributor:
    fullname: Yokoyama
– volume: 2
  start-page: S169
  issue: 4 Suppl 1
  year: 2003
  end-page: S177
  article-title: The molecular target of rapamycin (mTOR) as a therapeutic target against cancer
  publication-title: Cancer Biol Therapy
  contributor:
    fullname: Rowinsky
– article-title: Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice
  publication-title: Aging Cell
  contributor:
    fullname: Liu
– volume: 28
  start-page: 1652
  year: 2008
  end-page: 1655
  article-title: Total cerebral blood flow in relation to cognitive function: the Rotterdam Scan Study
  publication-title: J Cereb Blood Flow Metab
  contributor:
    fullname: Vernooij
– volume: 261
  start-page: 921
  year: 1993
  end-page: 923
  article-title: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
  publication-title: Science
  contributor:
    fullname: Strittmatter
– volume: 5
  start-page: e9979
  year: 2010
  article-title: Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease
  publication-title: PloS One
  contributor:
    fullname: Hart
– volume: 3
  start-page: 421
  year: 1997
  end-page: 428
  article-title: Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A
  publication-title: Nat Med
  contributor:
    fullname: Valentine
– volume: 2
  start-page: 1
  year: 2010
  end-page: 5
  article-title: Functional neuroimaging: a physiological perspective
  publication-title: Front Neuroenergetics
  contributor:
    fullname: Duong
– volume: 6
  start-page: 268ra179
  issue: 268
  year: 2014
  article-title: mTOR inhibition improves immune function in the elderly
  publication-title: Science translational medicine
  contributor:
    fullname: Huang
– volume: 462
  start-page: 359
  year: 2014
  end-page: 371
  article-title: Complex IV-deficient Surf1(-/-) mice initiate mitochondrial stress responses
  publication-title: Biochem J
  contributor:
    fullname: Liu
– volume: 6
  start-page: 742
  year: 2014
  end-page: 754
  article-title: Rapamycin-induced metabolic defects are reversible in both lean and obese mice
  publication-title: Aging
  contributor:
    fullname: Fernandez
– volume: 26
  start-page: 123
  issue: Suppl 3
  year: 2011
  end-page: 133
  article-title: Effects of hypoperfusion in Alzheimer's disease
  publication-title: J Alzheimer's Dis
  contributor:
    fullname: Meier
– volume: 287
  start-page: 41774
  year: 2012
  end-page: 41786
  article-title: APOE4-specific changes in Abeta accumulation in a new transgenic mouse model of Alzheimer disease
  publication-title: J Biol Chem
  contributor:
    fullname: Nwabuisi-Heath
– volume: 6
  start-page: 125
  year: 2011
  end-page: 129
  article-title: Common toxicities of mammalian target of rapamycin inhibitors
  publication-title: Target Oncol
  contributor:
    fullname: Brenner
– volume: 45
  start-page: 689
  year: 2015
  end-page: 703
  article-title: Brain structure and function related to depression in Alzheimer's disease: contributions from neuroimaging research
  publication-title: J Alzheimer's Dis
  contributor:
    fullname: Sultzer
– volume: 30
  start-page: S5
  issue: Suppl 2
  year: 2012
  end-page: S13
  article-title: Metabolic reserve as a determinant of cognitive aging
  publication-title: J Alzheimer's Dis
  contributor:
    fullname: Mattson
– volume: 33
  start-page: 1412
  year: 2013
  end-page: 1421
  article-title: Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease
  publication-title: J Cereb Blood Flow Metab
  contributor:
    fullname: Halloran
– volume: 103
  start-page: 7130
  year: 2006
  end-page: 7135
  article-title: Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Banwait
– volume: 485
  start-page: 512
  year: 2012
  end-page: 516
  article-title: Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
  publication-title: Nature
  contributor:
    fullname: Singh
– volume: 102
  start-page: 8299
  year: 2005
  end-page: 8302
  article-title: Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Alexander
– volume: 13
  start-page: 86
  year: 2014
  end-page: 92
  article-title: Hippocampus-related cognitive impairments in Young apoE4 targeted replacement mice
  publication-title: Neurodegener Dis
  contributor:
    fullname: Liraz
– volume: 34
  start-page: 1
  year: 2013
  end-page: 12
  article-title: Apolipoprotein E epsilon4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease
  publication-title: Neurobiol Aging
  contributor:
    fullname: Liu
– volume: 27
  start-page: 89
  year: 2011
  end-page: 98
  article-title: Deficits in spatial learning and memory is associated with hippocampal volume loss in aged apolipoprotein E4 mice
  publication-title: J Alzheimer's Dis
  contributor:
    fullname: Lin
– volume: 6
  start-page: 37
  year: 2014
  end-page: 48
  article-title: Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences
  publication-title: Clin Epidemiol
  contributor:
    fullname: Rocca
– volume: 70
  start-page: 440
  year: 2013
  end-page: 444
  article-title: Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease
  publication-title: JAMA Neurol
  contributor:
    fullname: Zlokovic
– volume: 98
  start-page: 3334
  year: 2001
  end-page: 3339
  article-title: Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Chen
– volume: 68
  start-page: 51
  year: 2014
  end-page: 58
  article-title: How longevity research can lead to therapies for Alzheimer's disease: the rapamycin story
  publication-title: Exp Gerontol
  contributor:
    fullname: Lin
– volume: 2012
  start-page: 907409
  year: 2012
  article-title: Multimodal MRI neuroimaging biomarkers for cognitive normal adults, amnestic mild cognitive impairment, and Alzheimer's disease
  publication-title: Neurol Res Int
  contributor:
    fullname: Fox
– volume: 12
  start-page: 723
  year: 2011
  end-page: 738
  article-title: Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
  publication-title: Nature Rev Neurosci
  contributor:
    fullname: Zlokovic
– volume: 34
  start-page: 1440
  year: 2014
  end-page: 1443
  article-title: Caloric restriction impedes age-related decline of mitochondrial function and neuronal activity
  publication-title: J Cereb Blood Flow Metab
  contributor:
    fullname: Jiang
– article-title: Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease
  publication-title: J Cereb Blood Flow Metab
  contributor:
    fullname: Ma
– volume: 107
  start-page: 8446
  year: 2010
  end-page: 8451
  article-title: Nonlinear coupling between cerebral blood flow, oxygen consumption, and ATP production in human visual cortex
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Hardies
– volume: 241
  start-page: 462
  year: 1988
  end-page: 464
  article-title: Nonoxidative glucose consumption during focal physiologic neural activity
  publication-title: Science
  contributor:
    fullname: Mintun
– volume: 65
  start-page: 744
  year: 2011
  end-page: 749
  article-title: Validation of VASO cerebral blood volume measurement with positron emission tomography
  publication-title: Magn Reson Med
  contributor:
    fullname: Lee
– volume: 101
  start-page: 284
  year: 2004
  end-page: 289
  article-title: Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Alexander
– volume: 8
  start-page: 1151
  year: 2014
  end-page: 1169
  article-title: Advances in MRI biomarkers for the diagnosis of Alzheimer's disease
  publication-title: Biomarker Med
  contributor:
    fullname: Mullins
– volume: 35
  start-page: 86
  year: 2015
  end-page: 94
  article-title: Human apolipoprotein E varepsilon4 expression impairs cerebral vascularization and blood-brain barrier function in mice
  publication-title: J Cereb Blood Flow Metab
  contributor:
    fullname: St-Amour
– volume: 67
  start-page: 93
  year: 2010
  end-page: 98
  article-title: APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging
  publication-title: Arch Neurol
  contributor:
    fullname: An
– volume: 31
  start-page: 991
  year: 2011
  end-page: 993
  article-title: Animal research: reporting in vivo experiments – the ARRIVE guidelines
  publication-title: J Cereb Blood Flow Metab
  contributor:
    fullname: Cuthill
– volume: 9
  start-page: 341
  year: 2014
  end-page: 354
  article-title: What have novel imaging techniques revealed about metabolism in the aging brain?
  publication-title: Future Neurol
  contributor:
    fullname: Rothman
– volume: 26
  start-page: 8048
  year: 2006
  end-page: 8056
  article-title: Spatial memory formation and memory-enhancing effect of glucose involves activation of the tuberous sclerosis complex-Mammalian target of rapamycin pathway
  publication-title: J Neurosci
  contributor:
    fullname: Moore
– volume: 44
  start-page: 109
  year: 2004
  end-page: 120
  article-title: Hippocampus: cognitive processes and neural representations that underlie declarative memory
  publication-title: Neuron
  contributor:
    fullname: Eichenbaum
– volume: 33
  start-page: 1605
  year: 2013
  end-page: 1611
  article-title: Decreased in vitro mitochondrial function is associated with enhanced brain metabolism, blood flow, and memory in Surf1-deficient mice
  publication-title: J Cereb Blood Flow Metab
  contributor:
    fullname: Deepa
– volume: 9
  start-page: 106
  year: 2013
  end-page: 118
  article-title: Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
  publication-title: Nature Rev Neurol
  contributor:
    fullname: Xu
– volume: 6
  start-page: 69
  year: 2011
  end-page: 94
  article-title: Clinical activity of mammalian target of rapamycin inhibitors in solid tumors
  publication-title: Target Oncol
  contributor:
    fullname: Vemulapalli
– volume: 36
  start-page: 2296
  year: 2015
  end-page: 2303
  article-title: Caloric restriction increases ketone bodies metabolism and preserves blood flow in aging brain
  publication-title: Neurobiol Aging
  contributor:
    fullname: Gao
– volume: 27
  start-page: 3
  year: 2011
  end-page: 20
  article-title: Brain fuel metabolism, aging, and Alzheimer's disease
  publication-title: Nutrition
  contributor:
    fullname: Roy
– ident: bibr14-0271678X15621575
  doi: 10.2147/CLEP.S37929
– ident: bibr25-0271678X15621575
  doi: 10.1016/j.neuron.2004.08.028
– ident: bibr3-0271678X15621575
  doi: 10.1001/archneurol.2009.913
– ident: bibr34-0271678X15621575
  doi: 10.1016/j.nut.2010.07.021
– ident: bibr20-0271678X15621575
  doi: 10.18632/aging.100688
– ident: bibr24-0271678X15621575
  doi: 10.1016/j.neurobiolaging.2015.03.012
– ident: bibr43-0271678X15621575
  doi: 10.1007/s11523-011-0174-9
– volume: 2
  start-page: S169
  issue: 4
  year: 2003
  ident: bibr47-0271678X15621575
  publication-title: Cancer Biol Therapy
  contributor:
    fullname: Mita MM
– ident: bibr7-0271678X15621575
  doi: 10.1073/pnas.2635903100
– ident: bibr36-0271678X15621575
  doi: 10.1016/S0197-4580(00)00130-5
– ident: bibr4-0271678X15621575
  doi: 10.1073/pnas.0500579102
– ident: bibr48-0271678X15621575
  doi: 10.1016/j.exger.2014.12.002
– ident: bibr15-0271678X15621575
  doi: 10.1038/jcbfm.2010.220
– volume: 2
  start-page: 1
  year: 2010
  ident: bibr29-0271678X15621575
  publication-title: Front Neuroenergetics
  contributor:
    fullname: Lin AL
– ident: bibr5-0271678X15621575
  doi: 10.1073/pnas.061509598
– ident: bibr12-0271678X15621575
  doi: 10.1038/jcbfm.2013.82
– ident: bibr33-0271678X15621575
  doi: 10.1038/jcbfm.2008.62
– ident: bibr39-0271678X15621575
  doi: 10.1074/jbc.M112.407957
– ident: bibr42-0271678X15621575
  doi: 10.1002/mrm.22667
– ident: bibr45-0271678X15621575
  doi: 10.1126/scitranslmed.3009892
– ident: bibr38-0271678X15621575
  doi: 10.1038/jcbfm.2013.116
– ident: bibr40-0271678X15621575
  doi: 10.1155/2012/907409
– ident: bibr17-0271678X15621575
  doi: 10.1159/000354777
– ident: bibr6-0271678X15621575
  doi: 10.1016/j.neurobiolaging.2012.04.017
– ident: bibr11-0271678X15621575
  doi: 10.1038/jcbfm.2014.172
– ident: bibr37-0271678X15621575
  doi: 10.3233/JAD-2011-110899
– ident: bibr26-0271678X15621575
  publication-title: J Cereb Blood Flow Metab
  contributor:
    fullname: Halliday MR
– ident: bibr46-0271678X15621575
  doi: 10.1007/s11523-011-0178-5
– ident: bibr30-0271678X15621575
  doi: 10.1073/pnas.0909711107
– ident: bibr31-0271678X15621575
  doi: 10.1038/jcbfm.2014.114
– ident: bibr8-0271678X15621575
  doi: 10.1038/nature11087
– ident: bibr23-0271678X15621575
  doi: 10.2217/bmm.14.42
– ident: bibr19-0271678X15621575
  doi: 10.1042/BJ20140291
– ident: bibr9-0271678X15621575
  doi: 10.3233/JAD-2011-0010
– ident: bibr32-0271678X15621575
  doi: 10.1523/JNEUROSCI.0671-06.2006
– ident: bibr13-0271678X15621575
  doi: 10.1371/journal.pone.0009979
– ident: bibr27-0271678X15621575
  doi: 10.1038/nm0497-421
– ident: bibr21-0271678X15621575
  doi: 10.1073/pnas.0509695103
– ident: bibr18-0271678X15621575
  doi: 10.3233/JAD-2011-110479
– ident: bibr35-0271678X15621575
  doi: 10.1111/j.1749-6632.1997.tb48479.x
– ident: bibr44-0271678X15621575
  publication-title: Aging Cell
  contributor:
    fullname: Hurez V
– ident: bibr28-0271678X15621575
  doi: 10.1126/science.3260686
– ident: bibr10-0271678X15621575
  doi: 10.1038/nrn3114
– ident: bibr2-0271678X15621575
  doi: 10.1126/science.8346443
– ident: bibr22-0271678X15621575
  doi: 10.3233/JAD-148007
– ident: bibr1-0271678X15621575
  doi: 10.1038/nrneurol.2012.263
– ident: bibr16-0271678X15621575
  doi: 10.1001/jamaneurol.2013.2152
– ident: bibr41-0271678X15621575
  doi: 10.2217/fnl.14.13
SSID ssj0008355
Score 2.5870948
Snippet Apolipoprotein E ɛ4 allele is a common susceptibility gene for late-onset Alzheimer's disease. Brain vascular and metabolic deficits can occur in cognitively...
Apolipoprotein E 4 allele is a common susceptibility gene for late-onset Alzheimer's disease. Brain vascular and metabolic deficits can occur in cognitively...
SourceID pubmedcentral
proquest
crossref
pubmed
sage
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 217
SubjectTerms Alzheimer Disease - complications
Alzheimer Disease - pathology
Animals
Apolipoprotein E4 - genetics
Blood-Brain Barrier - drug effects
Cerebrovascular Circulation - drug effects
Glucose Metabolism Disorders - drug therapy
Learning Disabilities - drug therapy
Learning Disabilities - prevention & control
Metabolic Diseases - drug therapy
Mice
Mice, Transgenic
Neuroimaging
Original
Secondary Prevention - methods
Secondary Prevention - trends
Sirolimus - pharmacology
Sirolimus - therapeutic use
Vascular Diseases - drug therapy
SummonAdditionalLinks – databaseName: Sage Journals GOLD Open Access 2024
  dbid: AFRWT
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbtNAEB6V9AAXVFqghhYtEqqEhGn2x3F8jKpGFRIcqlbkZu2u1zRS7US1cwgn7jwBr8eTdGbjDYQIxDHJbna9MzvzzY9nAN7wfl9rI21cqoGMVWZ0nGmexVlhbSqkS6wjP-THT4OLa_Vhkkx2oA7vwnQn2LyntCrckRfWdLvJG33aBRlP0ZbiKGUnaHygykrRom-rfOXtDk016BsKTy8qimxbyodcxuHttgewK1JUVD3YHY0vP1-tZTfiEZ_0iP8f0wK_Aptba24qsi10up1k-VummFde4z143KFONlqxyRPYcfU-HIxqtLirJTthPg_UO9j34eFZ6AF3AN8vUZdWSzutGZrlFpdmIXX1Hatcixx0O7VM1wXr2k98YYWjohRtw3CSph4Q85kvBoEfzxVrSTci0-KsCmUUIz8wo1SUZlnNcTdUQJaNbr_euGnl7n5--9GwLob0FK7H51dnF3HXviG2iMLa2AhbIhxSSkk8a2dKqcuULqXVhS9cr3lqNdWcszLRvBgqU0iHmtSgmOBWymfQq2e1OwQmBC-UFoU2KVeOW5whTJkNh9qiiFI6greBFvl8VaUj56GQ-R90i-B1IFaOp0nxEV272aLJydQiwCqyf41JMoWYNxMRPF8ReL2iGKA5LbN-BOkG6dcDqJT35i_19MaX9E5wiwjEIjghJsnDLfjrQ7z434Ev4ZEgIOKdRkfQa-8W7hhhVGtedbx_Dxg3HB4
  priority: 102
  providerName: SAGE Publications
Title Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease
URI https://journals.sagepub.com/doi/full/10.1177/0271678X15621575
https://www.ncbi.nlm.nih.gov/pubmed/26721390
https://search.proquest.com/docview/1826650829
https://search.proquest.com/docview/1859493292
https://pubmed.ncbi.nlm.nih.gov/PMC5167110
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB415QAXRFseBhotEqqEhJvuw3F8jKKGCqkIVa3Izdpdr1tLsRPV7iGcuPML-Hv8EmY2dp-CA8c4Xq2dmZ35ZvfLNwDv-cGB1kbaMFdDGarE6DDRPAmTzNpYSBdZR_uQx1-GR2fq8yyabUDU_RfGk_atKfareblfFReeW7ks7aDjiQ2-Hk8iPowxbQ160MP025XobfhFSOF5iyLmIUbi2c3Z5ICu0SWsWTDTxdS1RgyxBJIUkW-npQdY8yFl8hbvy6ei6TN42mJINl4_6xZsuGobdsYV1s_liu0xz-r02-Xb8HjSdXTbgZ8nmBnLlS0qhkW2xalZR0T9yErXoD_MC8t0lbG2mcQ5yxxJTDQ1w0GaOjosF17aAT8eKtZQpkMXxFHU1p7Rri4jYkm9Kpf4NCQHy8bz7xeuKN3l7x-_ataeCD2Hs-nh6eQobJsxhBYxVRMaYXMEN0opGY8iZ3Kp85iWmNWZl6HXPLaaFOSsjDTPRspk0mFeNLjouZXyBWxWi8q9AiYEz5QWmTYxV45bHCFMnoxG2mLAUTqAD50t0uVacyPlnSz5PRMG8K4zVoq_Jp126MotruqUCieCnyL51z1RohDBJiKAl2sDX8_YeUYA8R3TX99Awtx3v0F_9QLdrX8GsEdOkrZRof7rS7z-7ynewBNBOMPvCb2Fzebyyu0iSmpMHx6NpyffTvvQ-zTjfb9G_gB2lhQO
link.rule.ids 230,314,727,780,784,885,21966,27853,27924,27925,44945,45333,53791,53793
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB5BeygXBC2PUB5GQpWQCFo_skmOq6qrBdoeqq3YW2Q7TrtSk1016WE59c4v4O_xS5jxJkuXFYhjFDt2PGPPN-PRNwDveK-ntZE2LFRfhio1Okw1T8M0tzYW0kXWURzy5LQ_OlefJ9HkTqmvdgXrj5RWhTPyh_VqdxNTkkCEHycT9DvQWsXRfdhWCFlQxbcHw7Ov49UxjNDC5y9i-5A6_L6j3PjGuk3aAJqb-ZJ3kr68HRo-goctgGSDpcQfwz1X7cLeoELnuVywA-ZTOn2sfBd2Drtybnvw_QzNYrmw04qhh21xaNZloX5gpWtQGa6mlukqZ20liQuWO-KXaGqGnTSVc5jPPK8DPh4p1pCZQ_3DXlTTnlFIl1FWSb0o5zgb4oJlg6tvl25auuuftz9q1l4HPYHz4dH4cBS2lRhCi4CqCY2wBSIbpZSMk8iZQuoipv1lde456DWPrSb6OCsjzfNEmVw6NIoGdzy3Uj6FrWpWuefAhOC50iLXJubKcYs9hCnSJNEWTxulA3jfySKbLwk3Mt5xkv8htwDedsLKcDXpqkNXbnZTZ-Q1EfYU6b_aRKlC-JqKAJ4tBbwaUfTRM5ZpL4B4TfSrBsTKvf6mml56du4Ip4iYKoADUpKsU-i__sSL_234BnZG45Pj7PjT6Zd9eCAIX_hY0EvYaq5v3CtER4153e6DXzuQCYA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB7BVgIuCFoe4WkkVAmJ0PUjm_VxVboqrwpVrdhbZDsOXanJrpr0sJy48wv4e_wSZrzJwrICcYxiJ45nxvONPfkG4Dnv942x0sWFGshYaWtibbiOde5cKqRPnKd9yA9Hg8NT9XaSTNrcHPoXpp3B-hWlVeGIwmJN1j3Pi732jHEPQymOi-wEYw_0WGlyFbaU0irpwdZofPzpZLUUI7wIOYzYPqYOv84pN56x7pc2wOZmzuRviV_BF41vwc0WRLLRUuq34YqvtmFnVGEAXS7YLgtpnWG_fBuu73cl3Xbg2zG6xnLhphXDKNvhq1mXifqSlb5BhTifOmaqnLXVJD6z3BPHRFMz7GSopMN8Frgd8PJAsYZcHeog9qK69oy2dRllltSLco6jIT5YNjr_cuanpb_48fV7zdojoTtwOj442T-M22oMsUNQ1cRWuALRjVJKpsPE20KaIiUbcyYPPPSGp84QhZyTieH5UNlcenSMFq2eOynvQq-aVf4-MCF4rozIjU258txhD2ELPRwahyuOMhG86GSRzZekGxnveMn_kFsEzzphZTibdNxhKj-7rDOKnAh_Cv2vNolWCGG1iODeUsCrN4oBRsdS9yNI10S_akDM3Ot3qulZYOhOcIiIqyLYJSXJOqX-60c8-N-GT-Hax9fj7P2bo3cP4YYgiBG2gx5Br7m49I8RIDX2SWsGPwE5SgqZ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rapamycin+rescues+vascular%2C+metabolic+and+learning+deficits+in+apolipoprotein+E4+transgenic+mice+with+pre-symptomatic+Alzheimer%E2%80%99s+disease&rft.jtitle=Journal+of+cerebral+blood+flow+and+metabolism&rft.au=Lin%2C+Ai-Ling&rft.au=Jahrling%2C+Jordan+B&rft.au=Zhang%2C+Wei&rft.au=DeRosa%2C+Nicholas&rft.date=2017-01-01&rft.pub=SAGE+Publications&rft.issn=0271-678X&rft.eissn=1559-7016&rft.volume=37&rft.issue=1&rft.spage=217&rft.epage=226&rft_id=info:doi/10.1177%2F0271678X15621575&rft.externalDocID=10.1177_0271678X15621575
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0271-678X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0271-678X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0271-678X&client=summon